AffyXell, Avacta’s joint venture with Daewoong Pharmaceutical, expands its manufacturing partnership with GenScript ProBio for cell therapies

AffyXell, Avacta’s joint venture with Daewoong Pharmaceutical, expands its manufacturing partnership with GenScript ProBio for cell therapies
Visit here at 5 pm BST on Monday 16th May 2022 for the Pantheon Resources PLC update – Modelling Performance from Vertical to Horizontal Wells.
Avacta establishes new Therapeutics headquarters at Scale Space, Imperial College White City Campus
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is ADVFN, Avacta, Dukemount, Longboat, Ncondezi, Quadrise,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Avacta, Borders, Echo, Global, Mila, Power,
Share Talk are proud to be hosting the Pantheon Resources Plc – Shareholder Presentation and Q&A – Tuesday, April 26, 2022, at 5:30 PM BST.
Open Orphan (ORPH), a specialist contract research organisation, noted the announcement from Poolbeg Pharma (POLB), regarding a number of new investors having expressed interest in acquiring up to £1.6m of
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, is pleased to announce that a
i3 Energy (I3E), an independent oil and gas company with assets and operations in the UK and Canada, which has ticked all the right stock market boxes over the past
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Amigo, Angle, Avacta, Audioboom, Cadogan, Deltic,